Inventor
Richard M. Weinshilboum
Inventor
Rochester, MN, US
Overview
Patents· 35 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes45%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms28%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C07HSugars5%
A61KPreparations for medical, dental or toiletry purposes3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
A61BDiagnosis2%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
C12YEnzymes2%
PatentTitleYear
11,122,997Modulating the aryl hydrocarbon receptor system to treat major depressive disorder202110,815,534Methods and materials for treating estrogen receptor positive breast cancer202010,220,016Methods and materials for assessing chemotherapy responsiveness and treating cancer20198,137,977'Lipidomic approaches to determining drug response phenotypes in cardiovascular disease'20128,048,662'Sulfotransferase 1E1 sequence variants'20117,943,355'Sulfotransferase 1E1 sequence variants'20117,858,306'HSD3B1 sequence variants'20107,820,805'Sulfotransferase 2B1 pharmacogenetics'20107,803,921'Sulfotransferase 1E1 sequence variants'20107,745,187'Sulfotransferase sequence variants'20107,745,185'Sulfotransferase 1A3 sequence variants'20107,727,737'Kit for rapid determination of thiopurine methyltransferase activity'20107,674,583'Alterations in the copy number of the SULT1A1 gene'20107,560,259'Glutathione S-transferase sequence variants'20097,541,169'Sulfotransferase sequence variants'20097,514,215'Sulfotransferase SULT2A1 sequence variants'20097,485,711'CYP19A1 polymorphisms'20097,482,146'Phenylethanolamine-N-methyltransferase sequence variants'20097,452,689'Method for rapid determination of thiopurine methyltransferase activity'20087,425,624'Sulfotransferase 1A3 sequence variants'20087,390,894'Glutathione S-transferase sequence variants'20087,371,523'Phenylethanolamine-N-methyltransferase sequence variants'20087,288,641'Sulfotransferase 1E1 sequence variants'20077,288,399'3′-phosphoadenosine-5′-phosphosulfate synthetase 1 (PAPSS1) sequence variants'20077,288,642'Sulfotransferase 2B1 pharmacogenetics'20077,250,290'Arsenic methyltransferase sequence variants'20077,186,551'3′-phosphoadenosine -5′-phosphosulfate synthetase 2 (PAPSS2) sequence variants'20077,067,311'3′-phosphoadenosine-5′-phosphosulfate synthetase 1 (PAPSS1) sequence variants'20067,056,731'Sulfotransferase SULT2A1 sequence variants'20067,026,163'Sulfotransferase sequence variants'20066,316,188'Histamine-N-methyltransferase variants associated with histaminergic disease'20016,265,561'Sulfotransferase sequence variants'20015,744,355'cDNA cloning and expression of human liver estrogen sulfotransferase'19985,714,594'cDNA cloning and expression of human liver estrogen sulfotransferase'19985,470,737'Stably-transformed cells expressing human thiopurine methyltransferase'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2012Patents assigned to MAYO FOUNDATION (32)· patent assignee history
1995–2021Based in Rochester, MN, US· patent location history
2012–2021Patents assigned to UNIV DUKE (2)· patent assignee history
2012Patents assigned to BAILLIE REBECCA ANN (1)· patent assignee history
2012Patents assigned to CHILDRENS HOSP & RES CT OAK (1)· patent assignee history
2019–2021Patents assigned to MAYO FOUND MEDICAL EDUCATION & RES (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MAYO FOUNDATION | 32 | 1995–2012 |
| MAYO FOUND MEDICAL EDUCATION & RES | 3 | 2019–2021 |
| UNIV DUKE | 2 | 2012–2021 |
| BAILLIE REBECCA ANN | 1 | 2012 |
| CHILDRENS HOSP & RES CT OAK | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Rochester, Minnesota, US | 35 | 1995–2021 |